港股異動 | 藥師幫大升12%創近一年半新高 年內股價已翻倍!
藥師幫(9885.HK)午後繼續拉昇,一度大升12.35%至11.28港元,股價創2023年12月19日以來近一年半新高,年內累升103%,市值約77億港元。資金面上,基於對自身業績和未來市場的正面預期,藥師幫於今年5月宣佈啟動億元規模的股份回購計劃。格隆匯APP數據顯示,藥師幫昨日(6月5日)再度斥資59.56萬港元回購6萬股,自5月7日以來已累計回購超533萬股。股份購回計劃持續穩步推進,彰顯了藥師幫對自身股價以及公司未來長期發展的堅定信心。業績面上,藥師幫2024年度錄得收入179.04億元(人民幣,下同),同比增加5.5%;公司擁有人應占利潤3001.3萬元,同比扭虧為盈;每股盈利0.05元。公司擬向全體股東首次派發分紅,每股派發現金紅利0.075元,屬於高比例分紅回饋股東,也彰顯其穿越週期、穩健增長的盈利能力。消息面上,藥師幫6月3日晚間宣佈公司與越疆科技達成戰略合作,雙方將圍繞協作機器人及AI產品在醫藥領域的應用展開深度合作,共同探索智慧解決方案在醫藥研發、零售等全鏈場景的應用,推動醫藥產業與機器人技術的深度融合。有分析認為,藥師幫的數字化優勢和提前佈局,將有望在行業變革中發揮更大價值,賦能零售藥店實現新業態升級。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.